These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of R-(-)-alpha-methylhistamine and thioperamide on in vivo release of norepinephrine in the rat hippocampus. Di Carlo G, Ghi P, Orsetti M. Prog Neuropsychopharmacol Biol Psychiatry; 2000 Feb; 24(2):275-84. PubMed ID: 10800750 [Abstract] [Full Text] [Related]
23. [3H]-thioperamide as a radioligand for the histamine H3 receptor in rat cerebral cortex. Alves-Rodrigues A, Leurs R, Wu TS, Prell GD, Foged C, Timmerman H. Br J Pharmacol; 1996 Aug; 118(8):2045-52. PubMed ID: 8864541 [Abstract] [Full Text] [Related]
25. Thioperamide, a selective histamine H3 receptor antagonist, protects against PTZ-induced seizures in mice. Vohora D, Pal SN, Pillai KK. Life Sci; 2000 Apr 21; 66(22):PL297-301. PubMed ID: 10834305 [Abstract] [Full Text] [Related]
26. Pharmacological effects of carcinine on histaminergic neurons in the brain. Chen Z, Sakurai E, Hu W, Jin C, Kiso Y, Kato M, Watanabe T, Wei E, Yanai K. Br J Pharmacol; 2004 Nov 21; 143(5):573-80. PubMed ID: 15466447 [Abstract] [Full Text] [Related]
27. Pruritus-associated response mediated by cutaneous histamine H3 receptors. Sugimoto Y, Iba Y, Nakamura Y, Kayasuga R, Kamei C. Clin Exp Allergy; 2004 Mar 21; 34(3):456-9. PubMed ID: 15005741 [Abstract] [Full Text] [Related]
28. Release of acetylcholine in the ventral striatum is influenced by histamine receptors. Prast H, Fischer H, Philippu A. Agents Actions; 1994 Jun 21; 41 Spec No():C85-6. PubMed ID: 7976814 [Abstract] [Full Text] [Related]
29. Thioperamide, a histamine H3 receptor antagonist, increases GABA release from the rat hypothalamus. Yamamoto Y, Mochizuki T, Okakura-Mochizuki K, Uno A, Yamatodani A. Methods Find Exp Clin Pharmacol; 1997 Jun 21; 19(5):289-98. PubMed ID: 9379777 [Abstract] [Full Text] [Related]
30. Control of exocrine secretion in the guinea-pig pancreas by histamine H3 receptors. Jennings LJ, Salido GM, Pariente JA, Davison JS, Singh J, Sharkey KA. Can J Physiol Pharmacol; 1996 Jun 21; 74(6):744-52. PubMed ID: 8909787 [Abstract] [Full Text] [Related]
37. Clobenpropit (VUF-9153), a new histamine H3 receptor antagonist, inhibits electrically induced convulsions in mice. Yokoyama H, Onodera K, Maeyama K, Sakurai E, Iinuma K, Leurs R, Timmerman H, Watanabe T. Eur J Pharmacol; 1994 Jul 21; 260(1):23-8. PubMed ID: 7957622 [Abstract] [Full Text] [Related]
38. Binding characteristics of a histamine H3-receptor antagonist, [3H]S-methylthioperamide: comparison with [3H](R)alpha-methylhistamine binding to rat tissues. Yanai K, Ryu JH, Sakai N, Takahashi T, Iwata R, Ido T, Murakami K, Watanabe T. Jpn J Pharmacol; 1994 Jun 21; 65(2):107-12. PubMed ID: 7967223 [Abstract] [Full Text] [Related]
39. Differential effect of sodium ions and guanine nucleotides on the binding of thioperamide and clobenpropit to histamine H3-receptors in rat cerebral cortical membranes. Clark EA, Hill SJ. Br J Pharmacol; 1995 Jan 21; 114(2):357-62. PubMed ID: 7881735 [Abstract] [Full Text] [Related]
40. [The effect of central histamine H3 receptor on breathing activity of asthmatic guinea pigs]. Dong R, Zhang M, Lu BS. Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Feb 21; 22(1):117-21. PubMed ID: 21186598 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]